Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-06

FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)

View source ↗

Summary

The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid for inflammatory skin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desoximetasone topical (desoximetasone)

Snippet

ORIG AP for DESOXIMETASONE (DESOXIMETASONE)